Hybrid Capture NGS‐based assays combined with data analysis solutions for molecular tumor diagnostics and clinical research.


NEOs expertise lies in the development and optimization of Hybrid Capture NGS‐based solutions to support timely results in cancer diagnostics and clinical research.



NEO New Oncology offers reliable support to accommodate your needs - from implementing the technology and providing tailor-made trainings to supporting the evaluation of technically complex analyses.

*NEOplus v2 RUO. For research use only. Not for use in diagnostic procedures.


Hybrid Capture-based molecular tumor analysis in your lab


Learn more about our assays for diagnostics and clinical research


We are your partner in implementing an innovative molecular tumor analysis

Job offers

Join the global NEO team!

To top